These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33998707)

  • 1. Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors.
    Aoki S; Nakase K; Hayashi N; Nakaminami H; Noguchi N
    J Dermatol; 2021 Sep; 48(9):1365-1371. PubMed ID: 33998707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2017 Jan; 66(1):8-12. PubMed ID: 28218057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study.
    Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N
    J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Prevalence of Minocycline-Resistant
    Nakase K; Koizumi J; Fukumoto S; Hayashi N; Noguchi N; Nakaminami H
    Microb Drug Resist; 2022 Aug; 28(8):861-866. PubMed ID: 35723664
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
    Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
    Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
    Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
    Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene,
    Aoki S; Nakase K; Nakaminami H; Wajima T; Hayashi N; Noguchi N
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antimicrobial-resistant Cutibacterium isolates and development of multiplex PCR method for Cutibacterium species identification.
    Koizumi J; Nakase K; Hayashi N; Nasu Y; Hirai Y; Nakaminami H
    J Infect Chemother; 2023 Feb; 29(2):198-204. PubMed ID: 36336238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug Resistance Plasmid pTZC1 Could Be Pooled among
    Koizumi J; Nakase K; Hayashi N; Takeo C; Nakaminami H
    Microbiol Spectr; 2023 Feb; 11(2):e0362822. PubMed ID: 36847559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.